Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. - Wikidata - wikimedia - TriplyDB

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

http://www.wikidata.org/entity/Q34573562

about

Overview, prevention and management of chemotherapy extravasation Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity Vacuum-Sealing as a Treatment Option for Severe Anthracycline Extravasation in a Breast Cancer Patient.Dexrazoxane for the treatment of chemotherapy-related side effects.Scavenging effects of dexrazoxane on free radicals.Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment.Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines.Dexrazoxane for anthracycline extravasation.Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells.Management of anthracycline extravasation injuries.Local toxicity of antracycline extravasation.The use of dexrazoxane for the prevention of anthracycline extravasation injury.Anthracycline extravasation injuries: management with dexrazoxane.Massive breast necrosis after extravasation of a full anthracycline cycle.Management of anthracycline extravasation into the pleural space Extravasational side effects of cytotoxic drugs: A preventable catastrophe.Extravasation emergencies: state-of-the-art management and progress in clinical research.Dermatologic manifestations of cytotoxic therapy.Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.Treatment of anthracycline extravasations using dexrazoxane.Dexrazoxane: a management option for anthracycline extravasations.Extravasation injuries: a review.Management of the extravasation of anti-neoplastic agents.Describing Intravenous Extravasation in Children (DIVE Study).Supportive Treatments for Patients with Cancer.Development and Validation of New RP-HPLC Method for the Determination of Dexrazoxane.Video-assisted thoracoscopy in the management of intrapleural extravasation of cytotoxic chemotherapy.Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in rats.Pharmacological management of anticancer agent extravasation: A single institutional guideline.Savene® (dexrazoxane) use in clinical practice.Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane.Anthracycline extravasations: prevention and management.A Primer on the Acute Management of Intravenous Extravasation Injuries for the Plastic Surgeon.

P2860

Q26767033-F9582375-0744-4502-BB65-1ACF8D17B30A Q28301317-3B63F392-BE1A-436B-AC64-645DB4704862 Q34096302-EDB69E40-95AA-42E4-AB74-F440E48CBF8E Q34211957-79D577A9-9B5C-45AC-B97E-E05ADD66A517 Q34255271-9C27FB2A-139D-48F2-B11E-874BA0531C80 Q34631769-ED5EED88-7E97-4FE8-885B-B713B4898B4E Q34642851-C53DD9FB-BDE7-44AC-9127-3C816D67FCF3 Q34715947-5C614BEC-8F3F-41E5-8CE3-776F28EF224F Q35862550-E5602255-6B6D-4944-8D40-28C8C8085419 Q36841181-8210E3B4-5C74-4504-839B-E64784FB8566 Q36894091-94638E0F-AA67-4001-8140-C43ED0B64665 Q37071195-C8D219F6-53A3-4610-9824-B6D86A47D4A4 Q37230281-83F8776B-E8B0-47C1-99D2-A344FE36B5B1 Q37293019-A657F6A2-F946-4B63-8E31-2D5AA919DE05 Q37302166-2E135206-9BE2-4C2F-BE4C-DF76D1815668 Q37339220-6A6CEE11-5905-46E2-881D-1C91E47A350F Q37512213-028D70BA-6591-4458-9BF8-9338F64EDE62 Q37930714-66C38836-9E33-4A2A-A801-C9F582BB06C9 Q38081464-7DDD9256-D267-454C-BB82-C71BB20C9964 Q38129316-959070B0-5D51-47FD-9A99-0B9BF10C03AB Q38143321-B0060D17-7DA8-41E6-B770-44EB0DB43FCC Q38176727-DDF6226E-27AF-406B-952E-55E5AC9C51FC Q38364842-65B0F82C-63BC-4B5E-A983-C2BE2EB0A6A4 Q38860269-DA3ADB03-0F81-4AC8-BC24-493BE05203A5 Q41270171-5D130245-F199-4BB1-A02B-6D73A2112BBA Q41886287-46CE65B5-5EBD-4F0B-8AAF-C17734893696 Q42332701-B3F132FF-A65D-4218-96D4-6190C590C574 Q43108039-A994AA91-0687-492A-B652-DECB628CF4BB Q43789978-243104A7-B09C-4827-A241-28D6C785B524 Q47238461-0F237AB3-A1B3-42E3-A6D5-33E03525CDEC Q50146141-8A4A6E1F-DADE-467E-91B4-A00C5C59EBD1 Q51379332-CF75298B-203C-4612-97F9-09FD3E64F563 Q53142406-30186A35-7028-4205-9240-3C51B11137D8 Q55228896-FDB11A9B-81E2-480C-A1A0-A6F44C654622

P2860

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

http://www.wikidata.org/entity/Q34573562

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Treatment of anthracycline ext ...... clinical multicentre studies.

@ast

Treatment of anthracycline ext ...... clinical multicentre studies.

@en

Treatment of anthracycline extravasation with Savene

@nl

type

label

Treatment of anthracycline ext ...... clinical multicentre studies.

@ast

Treatment of anthracycline ext ...... clinical multicentre studies.

@en

Treatment of anthracycline extravasation with Savene

@nl

prefLabel

Treatment of anthracycline ext ...... clinical multicentre studies.

@ast

Treatment of anthracycline ext ...... clinical multicentre studies.

@en

Treatment of anthracycline extravasation with Savene

@nl

P1433

Q34573562-C0A4D6F5-1D07-44FD-9DF7-4759380B2D7C

P1476

Q34573562-E9F68F62-6BE3-47BF-BE24-AD401DD46624

P2093

Q34573562-01EEC762-4DE2-441B-9242-795141B71928

Q34573562-0A7209DC-58D6-4968-B56D-6D199434F9B2

Q34573562-1FBEA761-AA4B-4878-98EA-7BD219311C80

Q34573562-4F6E6690-68C7-419A-A678-6D2EA6710893

Q34573562-55FCB566-6E9B-471C-8E1C-D82F6EF5B302

Q34573562-77A67506-1E61-4947-9B8B-D020AF8CC19B

Q34573562-B8AEBE38-3746-4FF4-9476-8B92161AD334

Q34573562-C09AF4FD-8A02-4EA5-A537-3CAB063432F6

Q34573562-CEE86996-0230-4D3E-A4CC-C339C1659479

Q34573562-DD64B125-0903-460E-B277-25FEE4911E69

P304

Q34573562-18E66320-F443-463F-82EE-F082CDFF2993

P31

Q34573562-B647F088-DB8A-4693-B32C-45C4E331038D

P356

Q34573562-2ADEF03D-5334-499A-9555-7607A27C9F5E

P433

Q34573562-7F7D48E7-001A-4313-958C-D044F081F6E5

P478

Q34573562-A3653BA1-1286-469F-BA45-40EA95590B20

P577

Q34573562-4174316B-1800-411C-AC92-44232A0C4392

P5875

Q34573562-DF0BD294-6C5D-4FA3-8263-CEA65C27AD23

P698

Q34573562-4FE96B37-E217-40E4-B7DD-27410A0D58B5

P921

Q34573562-A0F0627D-0DED-4993-AD88-95A567B108CE

P356

P1433

Annals of Oncology

P1476

Treatment of anthracycline ext ...... clinical multicentre studies.

@en

P2093

A Rasmussen

http://www.w3.org/2001/XMLSchema#string

G Giaccone

http://www.w3.org/2001/XMLSchema#string

G Rosti

http://www.w3.org/2001/XMLSchema#string

H Eidtmann

http://www.w3.org/2001/XMLSchema#string

H T Mouridsen

http://www.w3.org/2001/XMLSchema#string

J Buter

http://www.w3.org/2001/XMLSchema#string

K Dahlstrøm

http://www.w3.org/2001/XMLSchema#string

M de Wit

http://www.w3.org/2001/XMLSchema#string

P B Jensen

http://www.w3.org/2001/XMLSchema#string

P Knoblauch

http://www.w3.org/2001/XMLSchema#string

P304

546-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDL413

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6614188

http://www.w3.org/2001/XMLSchema#string

P698

17185744

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial